Author

P. R. Lephart

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:virus· 1

Frequent Co-Authors

D. W. Newton· 1 shared K. Barron· 1 shared L. Schroeder· 1 shared M. A. Bachman· 1 shared S. W. McClellan· 1 shared W. LeBar· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

D. W. Newton

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.

P. R. Lephart, M. A. Bachman, W. LeBar, S. W. McClellan, K. Barron, L. Schroeder, D. W. Newton

This study compares four SARS-CoV-2 NAAT platforms, finding that ID NOW performs worse than others, especially with nasal swabs and in chronically infected patients.

bioRxiv · Jun 4, 2020Microbiology